Eltrombopag use for refractory immune thrombocytopenia in pregnancy: A case report

• Asıl Yazarlar: Sarah J. Weingarten (Yazar), Deborah Friedman (Yazar), Anubha Arora (Yazar)
• Materyal Türü: Kitap
• Baskı/Yayın Bilgisi: Elsevier, 2021-01-01T00:00:00Z.
• Konular: article
• Online Erişim: Connect to this object online.

Background: Immune thrombocytopenic purpura (ITP) is a rare autoimmune disorder that involves platelet destruction in the spleen. Eltrombopag (Promacta®), a thrombopoietin agonist, has been used in non-pregnant patients to manage ITP, but few cases of its use in pregnancy have been reported. Case Pr...